Literature DB >> 27193433

Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.

Toshio Takagi1, Tsunenori Kondo2, Kenji Omae2, Junpei Iizuka2, Hirohito Kobayashi2, Kazuhiko Yoshida2, Yasunobu Hashimoto2, Kazunari Tanabe2.   

Abstract

PURPOSE: We analyzed trends related to surgical approach for renal cell carcinoma (RCC), including partial nephrectomy (PN) or radical nephrectomy (RN), in patients with stage 4 chronic kidney disease (CKD), and identified predictors for postoperative progression to end-stage renal disease (ESRD) requiring permanent dialysis.
METHODS: We enrolled patients with stage 4 CKD who underwent surgery for non-metastatic RCC. We compared their characteristics according to surgical approach (PN vs. RN). Moreover, predictors for postoperative progression to requiring permanent dialysis were determined using multivariable analyses. The Charlson comorbidity index (CCI) was adjusted for age.
RESULTS: Fifty-one patients (PN 23, RN 28) were evaluated in the present study. Their mean preoperative estimated glomerular filtration rate (eGFR) was 24 ml/min/1.73 m(2), and four patients had a solitary kidney. Three of 23 patients (13 %) who underwent PN progressed to requiring dialysis after surgery after a median 16 months. In contrast, 13 of 28 patients (46 %) who underwent RN developed dialysis immediately after surgery (median 2 days). Patients who underwent PN had lower T stages (T1, PN 100 % vs. RN 50 %, p = 0.004) and smaller tumors (31 mm vs. 65 mm, p < 0.0001) than did those who underwent RN. RN and lower preoperative eGFR significantly predicted progression to requiring dialysis, while tumor size and CCI did not.
CONCLUSIONS: PN tended to be selected for patients with lower T stage and smaller tumors in the limited cohort of stage 4 CKD patients. PN had a significant benefit of preventing dialysis in the multivariable analysis.

Entities:  

Keywords:  Chronic kidney disease; Kidney neoplasm; Nephrectomy

Mesh:

Year:  2016        PMID: 27193433     DOI: 10.1007/s11255-016-1317-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

1.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

2.  The management of a clinical t1b renal tumor in the presence of a normal contralateral kidney.

Authors:  Christopher J Weight; David C Miller; Steven C Campbell; Ithaar H Derweesh; Brian R Lane; Edward M Messing
Journal:  J Urol       Date:  2013-01-18       Impact factor: 7.450

3.  Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours.

Authors:  Christopher J Weight; Gregory Lieser; Benjamin T Larson; Tianming Gao; Brian R Lane; Steven C Campbell; Inderbir S Gill; Andrew C Novick; Amr F Fergany
Journal:  Eur Urol       Date:  2010-05-18       Impact factor: 20.096

4.  Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.

Authors:  Emil Scosyrev; Edward M Messing; Richard Sylvester; Steven Campbell; Hendrik Van Poppel
Journal:  Eur Urol       Date:  2013-07-02       Impact factor: 20.096

Review 5.  2004 WHO classification of the renal tumors of the adults.

Authors:  Antonio Lopez-Beltran; Marina Scarpelli; Rodolfo Montironi; Ziya Kirkali
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

6.  Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer.

Authors:  Hung-Jui Tan; Edward C Norton; Zaojun Ye; Khaled S Hafez; John L Gore; David C Miller
Journal:  JAMA       Date:  2012-04-18       Impact factor: 56.272

7.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

8.  Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

Authors:  William C Huang; Elena B Elkin; Andrew S Levey; Thomas L Jang; Paul Russo
Journal:  J Urol       Date:  2008-11-13       Impact factor: 7.450

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Risk of end-stage renal disease after cancer nephrectomy in Taiwan: a nationwide population-based study.

Authors:  Wei-Yu Lin; Fu-Wen Liang; Tsung-Hsueh Lu
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

View more
  4 in total

1.  Predictors of long-term renal function after kidney surgery for patients with preoperative chronic kidney disease.

Authors:  Andrew Silagy; Emily Zabor; Roy Mano; Renzo DiNatale; Julian Marcon; Mahyar Kashani; Kyle Blum; Eduard Reznik; Edgar Jaimes; Jonathan Coleman; A Ari Hakimi; Paul Russo
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

Review 2.  Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients.

Authors:  Aleksandra Semeniuk-Wojtaś; Arkadiusz Lubas; Rafał Stec; Cezary Szczylik; Stanisław Niemczyk
Journal:  Int J Mol Sci       Date:  2016-12-09       Impact factor: 5.923

3.  Outcomes of arteriovenous access among cancer patients requiring chronic haemodialysis.

Authors:  Seonjeong Jeong; Hyunwook Kwon; Jai Won Chang; Youngjin Han; Tae-Won Kwon; Yong-Pil Cho
Journal:  BMC Nephrol       Date:  2020-07-23       Impact factor: 2.388

4.  Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.

Authors:  Qing-Shui Wang; Feng Li; Zi-Qiang Liao; Ke Li; Xin-Liu Yang; You-Yu Lin; Yi-Lin Zhao; Shu-Yun Weng; Yun Xia; Yan Ye; Su-Huan Li; Chen-Yi Wang; Yao Lin
Journal:  Cancer Med       Date:  2019-06-10       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.